What's New in Parkinson's - Davis Phinney Foundation
5 days ago · December News. A meta-analysis found that tai-chi, yoga, and weight-training can help with dynamic balance for people with Parkinson’s.; Tavapon, a new drug being developed by Abbvie showed signs of improving mobility for people with early-stage Parkinson’s.; A small study reports that sub-optimal settings of DBS systems can impact sleep metrics related to sleep spindle density.
Parkinson's News Today Home | Parkinson's News Today
Top 10 Parkinson’s stories of 2024. In 2024, Parkinson’s News Today kept readers informed with updates on the latest research, treatments, and clinical trials for Parkinson’s disease. Here are the 10 most-read stories in 2024, each with a short summary.
New Parkinson’s drug could slow or reverse progression of disease ...
Aug 21, 2024 · “People with Parkinson’s should be aware that although the findings were interesting, this was only a safety, tolerability and immunogenicity study, and thus there is a long way to go for development of this treatment,” Michael S. Okun, M.D., Parkinson’s Foundation medical adviser and director at the Norman Fixel Institute for ...
Parkinson's News - ScienceDaily
4 days ago · Information on Parkinson's disease. Learn about Parkinson's disease treatments, symptoms, new research and medication.
Top Parkinson’s Science News Articles of 2024
Dec 10, 2024 · Our Science News article series highlight exciting Parkinson’s studies and how they impact those living with this disease. Explore our top Science News articles of 2024. ... Every day, researchers are working hard to identify the mechanisms in the brain that are responsible for Parkinson’s disease (PD) and its symptoms. In 2024, scientists ...
Parkinson's disease - Latest research and news | Nature
2 days ago · Parkinson's disease is a progressive neurodegenerative disorder, which is characterized by motor symptoms such as tremor, rigidity, slowness of movement and problems with gait. Motor symptoms...
Risvodetinib may slow Parkinson's progression, clinical trial...
Mar 11, 2024 · Risvodetinib, an oral therapy being developed by Inhibikase Therapeutics for Parkinson’s disease, appears to stabilize disease status and severity, according to data covering 25 patients who finished 12 weeks of dosing in an ongoing Phase 2 clinical trial.
News Archives - Parkinson's News Today
Deep brain stimulation may reverse Parkinson’s-driving inflammation. The use of deep brain stimulation — in which an electrode is surgically implanted in the brain — may hold promise to reverse inflammation, a key driver of Parkinson’s disease progression, according to a new study led by researchers in Germany.
New Findings About Key Pathological Protein in Parkinson’s Disease …
Dec 18, 2023 · A so-called pathological protein long associated with Parkinson’s disease has been found in a new study to trigger cells to increase protein synthesis, an event that eventually kills the subset of brain cells that die off in this neurodegenerative condition.
A Potential Parkinson’s Treatment Has Promising Results
Jun 20, 2024 · A small new trial published in the journal Nature Medicine describes what would be two firsts for Parkinson's disease, if they pan out: a diagnostic test and a potential immune-based...